Argatroban Solution for Infusion
Product Description
Ethypharm
-
Country/Region:France
-
Founded:1977
-
On CPHI since:2015
-
Certificates:4
-
Employees:1000 - 4999
Company types
Primary activities
Categories
Specifications
Ethypharm
-
Country/Region:France
-
Founded:1977
-
On CPHI since:2015
-
Certificates:4
-
Employees:1000 - 4999
Company types
Primary activities
More Products from Ethypharm (62)
-
Product Acetylcysteine 200 mg/ml
Paracetamol overdose treatment -
Product Aciclovir 250 mg
Treatment & prevention of Herpes Simplex and treatment of Varicella Zoster infections -
Product Adrenaline (Epinephrine) Solution for Injection
Adrenaline Solution for Injection is a fast-acting emergency medicine used for the treatment of life-threatening conditions such as anaphylaxis and cardiac arrest. It contains epinephrine, a potent sympathomimetic agent that stimulates alpha and beta-adrenergic receptors, resulting in rapid vasoconstrictio... -
Product Alprostadil 20 μg
Symptomatic treatment of peripheral occlusiveartery disease (PAD) in Leriche-Fontaine stages IIIand IV, excluding patients who are candidates foramputations -
Product Ampoules
Ethypharm has 2 sites for sterile ampoules manufacturing -
Product Aprepitant
Prevention of nausea and vomiting associatedwith highly and moderately emetogenic cancerchemotherapy -
Product Atosiban Acetate
Delay imminent preterm birth -
Product Atropine Sulfate
To reduce salivary and bronchial secretion.To treat bradycardia induced by drugs or toxicsubstances and acute myocardial infarction -
Product Azithromycin 500 mg
Treatment of the infections, caused by micro-organismssensitive to azithromycin -
Product Buprenorphine / Naloxone Sublingual Tablets
Buprenorphine/Naloxone Sublingual Tablets are indicated for the treatment of opioid dependence as part of a comprehensive medical, social, and psychological support program. The combination of buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist, is designed to reduce withdrawal symp... -
Product Buprenorphine Hydrochloride
Buprenorphine Oral Lyophilisate is a rapidly dispersing formulation designed for the treatment of opioid dependence as part of a comprehensive care program including medical, social, and psychological support. The product contains buprenorphine, a partial opioid agonist that helps reduce withdrawal symptom... -
Product Buprenorphine Hydrochloride Sublingual tablet
Substitution treatment for opioid drug dependence,within a framework of medical, social andpsychological treatment
Ethypharm resources (1)
-
Brochure Product List 2026
This is a brochure consist of the product portfolio of Ethypharm.


